They observed that fragile-site associated tumor suppressor (FATS), a novel oncogene involved in LC, was significantly downregulated in NSCLC tissues compared with adjacent normal tissues and was associated with the survival of NSCLC patients. The gene discussed is C10orf90; the disease is non-small cell lung carcinoma.